NCT00000438View on ClinicalTrials.gov

Naltrexone Treatment for Alcoholism

PHASE4CompletedINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

Not specified

Study Completion Date

March 31, 2003

Conditions
Alcoholism
Interventions
DRUG

naltrexone (Revia)

Trial Locations (1)

21205

Johns Hopkins Hospital, Baltimore

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Johns Hopkins University

OTHER

NCT00000438 - Naltrexone Treatment for Alcoholism | Biotech Hunter | Biotech Hunter